Pre-Lecture Quiz
... considered the primary pacemaker of the heart. 2. Afterload refers to the degree of stretch of the ventricular cardiac muscle fibers at the end of diastole. 3. Hypertension is defined as a systolic BP that is consistently greater than 140 mm Hg or a diastolic BP greater than 90 mm Hg. 4. An elevated ...
... considered the primary pacemaker of the heart. 2. Afterload refers to the degree of stretch of the ventricular cardiac muscle fibers at the end of diastole. 3. Hypertension is defined as a systolic BP that is consistently greater than 140 mm Hg or a diastolic BP greater than 90 mm Hg. 4. An elevated ...
Ivabradine (Procoralan) for the indication chronic heart failure
... the Health Insurance Regulation for the above-mentioned indication. ...
... the Health Insurance Regulation for the above-mentioned indication. ...
Common Cardiac Arrhythmias
... Underlying sinus rhythm with supraventricular premature complexes ...
... Underlying sinus rhythm with supraventricular premature complexes ...
Supplemental Table 1
... Supplemental Table 1. Serious cardiac outcome definitions. a Outcome Death Myocardial Infarction (MI) ...
... Supplemental Table 1. Serious cardiac outcome definitions. a Outcome Death Myocardial Infarction (MI) ...
Top 5 Ways to Prevent a Second Cardiac Event
... » 5 to 30% of deaths are sudden in nature Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol. ...
... » 5 to 30% of deaths are sudden in nature Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol. ...
HT, LDL , DM, etc
... unexpected loss of heart function, breathing and consciousness. Sudden cardiac arrest usually results from an electrical disturbance in your heart that disrupts its pumping action, stopping blood flow to the rest of your body. Sudden cardiac arrest is different from a heart attack, which occurs when ...
... unexpected loss of heart function, breathing and consciousness. Sudden cardiac arrest usually results from an electrical disturbance in your heart that disrupts its pumping action, stopping blood flow to the rest of your body. Sudden cardiac arrest is different from a heart attack, which occurs when ...
EKG
... An electrocardiogram (EKG or ECG) is a graphic representation of the heart’s electrical activity. ...
... An electrocardiogram (EKG or ECG) is a graphic representation of the heart’s electrical activity. ...
Major Compulsory Revisions - Journal of Cardiothoracic Surgery
... pain, with a major mechanism of action being selective blockading of cardiac sympathetic [10, 11]. Kock et al. have reported that TEA can improve the left ventricular function during stress-induced myocardial ischemia in patients with coronary artery disease [12]. In addition, we have previously rep ...
... pain, with a major mechanism of action being selective blockading of cardiac sympathetic [10, 11]. Kock et al. have reported that TEA can improve the left ventricular function during stress-induced myocardial ischemia in patients with coronary artery disease [12]. In addition, we have previously rep ...
2008 ACC/AHA/HRS Guidelines for Implantable
... Potential complications include, but are not limited to, rejection phenomena, erosion through the skin, muscle or nerve stimulation, oversensing, failure to detect and/or terminate tachyarrhythmia episodes, acceleration of ventricular tachycardia, and surgical complications such as hematoma, infecti ...
... Potential complications include, but are not limited to, rejection phenomena, erosion through the skin, muscle or nerve stimulation, oversensing, failure to detect and/or terminate tachyarrhythmia episodes, acceleration of ventricular tachycardia, and surgical complications such as hematoma, infecti ...
Surgical Therapy for Heart Failure
... LV Reconstruction for Nonischemic Cardiomyopathy Cardiomyoplasty experience has led to other novel approaches to heart failure. Observations suggested that some patients benefited from the diastolic "girdling" effect of the muscle wrap This observation led to the development of the Acorn device and ...
... LV Reconstruction for Nonischemic Cardiomyopathy Cardiomyoplasty experience has led to other novel approaches to heart failure. Observations suggested that some patients benefited from the diastolic "girdling" effect of the muscle wrap This observation led to the development of the Acorn device and ...
Slide 1
... A Syndrome of Epidemic Proportions • Approximately 4.9 million cases in the United States today • Over 400,000 new cases per year • The most common cause of hospitalization in people over 65 years • Increasing numbers of CHF patients due to the aging population ...
... A Syndrome of Epidemic Proportions • Approximately 4.9 million cases in the United States today • Over 400,000 new cases per year • The most common cause of hospitalization in people over 65 years • Increasing numbers of CHF patients due to the aging population ...
For ranolazine study
... artery disease with left ventricular dysfunction. Material and methods Inclusion criteria: Obstructive coronary artery disease patients with echocardiogram wise having left ventricular dysfunction of ejection fraction of <40% with normal QT on ECG a. chronic stable angina b. b. acute coronary syndro ...
... artery disease with left ventricular dysfunction. Material and methods Inclusion criteria: Obstructive coronary artery disease patients with echocardiogram wise having left ventricular dysfunction of ejection fraction of <40% with normal QT on ECG a. chronic stable angina b. b. acute coronary syndro ...
Hospital X Is Among First Hospitals in U
... [Insert location] – [insert date] – Physicians at [institution] are the first in the [state] to treat patients who suffer from irregular heartbeats with the latest implantable cardiac rhythm device technology. Medtronic’s Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and card ...
... [Insert location] – [insert date] – Physicians at [institution] are the first in the [state] to treat patients who suffer from irregular heartbeats with the latest implantable cardiac rhythm device technology. Medtronic’s Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and card ...
PERIPARTUM CARDIOMYOPATHY
... Fetal growth is dependent on good blood flow to the uterus and placenta ...
... Fetal growth is dependent on good blood flow to the uterus and placenta ...
Peripartum cardiomyopathy
... Fetal growth is dependent on good blood flow to the uterus and placenta ...
... Fetal growth is dependent on good blood flow to the uterus and placenta ...
Hospital X Is Among First Hospitals in U
... [Insert location] – [insert date] – Physicians at [institution] are the first in the [state] to treat patients who suffer from irregular heartbeats with the latest implantable cardiac rhythm device technology. Medtronic’s Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and card ...
... [Insert location] – [insert date] – Physicians at [institution] are the first in the [state] to treat patients who suffer from irregular heartbeats with the latest implantable cardiac rhythm device technology. Medtronic’s Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and card ...
Slide 1 - AccessMedicine
... with normal cardiac performance, there is a steep and positive relationship between increased cardiac filling pressures (as estimated from the left ventricular end-diastolic or pulmonary capillary wedge pressure) and increased stroke volume or cardiac output (top curve). By comparison, during progre ...
... with normal cardiac performance, there is a steep and positive relationship between increased cardiac filling pressures (as estimated from the left ventricular end-diastolic or pulmonary capillary wedge pressure) and increased stroke volume or cardiac output (top curve). By comparison, during progre ...
Why We Respect Randomized Controlled Clinical Trials in Heart
... mortality in heart failure patients. We have also seen the case where devices have been shown to be associated with adverse events such as the atherectomy catheter in coronary artery disease patients, despite better surrogate outcomes. With a device that was believed to be as innocuous as adaptive s ...
... mortality in heart failure patients. We have also seen the case where devices have been shown to be associated with adverse events such as the atherectomy catheter in coronary artery disease patients, despite better surrogate outcomes. With a device that was believed to be as innocuous as adaptive s ...
Is Your Patient HuFfing and PuEFing? (HFPEF)
... and beta-blockers have all failed to show a convincing impact ...
... and beta-blockers have all failed to show a convincing impact ...
INTRODUCTION It gives us great pleasure to
... It is known that failing heart is the main problem of cardiovascular medicine today. Heart failure due to cardiovascular disease is associated with contractile dysfunction and high risk of lifethreatening arrhythmias, with up to 50% of mortality attributable to sudden cardiac death. Sudden cardiac d ...
... It is known that failing heart is the main problem of cardiovascular medicine today. Heart failure due to cardiovascular disease is associated with contractile dysfunction and high risk of lifethreatening arrhythmias, with up to 50% of mortality attributable to sudden cardiac death. Sudden cardiac d ...
Management of Chronic Heart Failure in Adults: Synopsis of the
... the combined end point of mortality and hospitalization Combination therapy of ARBs and ACE inhibitors increases risk of hyperkalemia Adding ARB to ACE inhibitor and ß-blocker reduces the mortality and hospitalization caused by HF ...
... the combined end point of mortality and hospitalization Combination therapy of ARBs and ACE inhibitors increases risk of hyperkalemia Adding ARB to ACE inhibitor and ß-blocker reduces the mortality and hospitalization caused by HF ...
Biventricular Devices for Treatment of Congestive Heart Failure
... mode of therapy for heart failure and have made important inroads in the high risk of death that many heart failure patients face. However, patients with extreme forms of heart failure often remain highly symptomatic despite maximum medical therapy, and face grave risk Another one of the manifestati ...
... mode of therapy for heart failure and have made important inroads in the high risk of death that many heart failure patients face. However, patients with extreme forms of heart failure often remain highly symptomatic despite maximum medical therapy, and face grave risk Another one of the manifestati ...
Biventricular Devices for Treatment of Congestive Heart Failure
... mode of therapy for heart failure and have made important inroads in the high risk of death that many heart failure patients face. However, patients with extreme forms of heart failure often remain highly symptomatic despite maximum medical therapy, and face grave risk Another one of the manifestati ...
... mode of therapy for heart failure and have made important inroads in the high risk of death that many heart failure patients face. However, patients with extreme forms of heart failure often remain highly symptomatic despite maximum medical therapy, and face grave risk Another one of the manifestati ...
Are heart pumps saving lives?
... Mechanical pumps called ventricular assist devices (VADs) take over some of the work of the heart. By helping the ventricles pump blood—easing the workload of the heart in patients with heart failure— these heart pumps are saving lives. ...
... Mechanical pumps called ventricular assist devices (VADs) take over some of the work of the heart. By helping the ventricles pump blood—easing the workload of the heart in patients with heart failure— these heart pumps are saving lives. ...
Cardiac contractility modulation
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.